Quest Diagnostics

Global News

Quintiles launches new solution for emerging Asia-Pacific biopharmaceutical companies

Thursday, May 28, 2015 03:06 PM

Global CRO Quintiles has launched a new solution set tailored to meet the needs of emerging biopharmaceutical companies in the Asia-Pacific healthcare market.

More... »

EMD Serono makes key oncology appointments

Thursday, May 28, 2015 02:54 PM

EMD Serono, the U.S. biopharmaceutical business of Germany’s Merck, has announced two critical management appointments to lead its entry into oncology. EMD Serono's diversified oncology and immuno-oncology pipeline includes multiple, high-priority projects currently in development to optimize patient outcomes in challenging cancers that have significant unmet patient need.

More... »

Rho named a Best CRO with Life Sciences Award

Thursday, May 28, 2015 02:44 PM

Rho, a privately-held global CRO, recently was recognized as one of the Best CROs by the Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham, Chapel Hill region of North Carolina, where Rho is headquartered.

More... »

CISCRP Medical Heroes Appreciation event returns to DIA to celebrate clinical trial volunteers

Wednesday, May 27, 2015 01:38 PM

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit organization, has announced the upcoming Medical Heroes Appreciation Walk in Washington D.C. to honor the volunteers who give the gift of participation in clinical research and to raise awareness about the importance of clinical research in advancing public health.

More... »

Qiagen launches clinical bioinformatics platform for next-generation sequencing

Wednesday, May 27, 2015 12:24 PM

Qiagen, a Netherlands-based holding company, has launched its Qiagen Clinical Insight (QCI) bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS). The first two supported applications for the bioinformatics platform are in oncology for somatic and hereditary cancer testing.

More... »

Bayer to restructure

Wednesday, May 27, 2015 12:23 PM

The Bayer Group has released a financial update for 2014. The company had strengthened its life science businesses HealthCare and CropScience through acquisitions and decided to demerge the MaterialScience business. Dr. Marijn Dekkers, management board chairman, also listed four strategic priorities for Bayer’s successful further development.

More... »

AVEO Oncology relocates corporate headquarters in Massachusetts

Wednesday, May 27, 2015 12:22 PM

AVEO Oncology, a biopharmaceutical company developing targeted therapies through biomarker-driven insights, has relocated its corporate headquarters to Cambridge, Mass.

More... »

Parexel enhances ClinPhone RTSM service

Wednesday, May 27, 2015 12:21 PM

Global CRO Parexel International has launched enhancements to its Randomization and Trial Supply Management (RTSM) service, ClinPhone RTSM. Parexel designed the enhanced service to simplify patient randomization and clinical supply management and to offer greater speed and flexibility in tailoring the service to meet the needs of clinical trials, while reducing delivery timelines. For the improvements, Parexel integrated the interactive response technology acquired from ClinIntel in October 2014 with Parexel’s experience in delivering RTSM services to thousands of studies to create an enhanced fourth-generation technology platform.

More... »

Mylan clarifies Perrigo offer

Wednesday, May 27, 2015 12:18 PM

Mylan was asked by the Irish Takeover Panel to issue the following clarification and retraction in accordance with the Irish Takeover Rules, relating to its firm intention to make an offer to acquire Perrigo. The clarification and retraction relates to certain forward-looking statements made by Mylan specifically during the pendency of the offer period concerning its long-stated target since 2012 of at least $6 in adjusted diluted earnings per share (EPS) by 2018, including recently in Mylan's first quarter earnings press release of May 5.

More... »

AbbVie completes acquisition of Pharmacyclics

Wednesday, May 27, 2015 12:17 PM

AbbVie has completed the acquisition of Pharmacyclics, enhancing AbbVie's scientific and commercial presence in oncology. Pharmacyclics primarily is aligned with the $24 billion global hematological oncology market with Imbruvica (ibrutinib), a BTK-inhibitor used to treat hematological cancers.

More... »



June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs